Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2020 May 7;29(8):1564–1569. doi: 10.1158/1055-9965.EPI-19-1199

Figure 1: Overview of timing of study measures.

Figure 1:

The figure illustrates how the study design was administered. One week prior to the PCP visit the patient underwent a phone eligibility survery. At the day of the visit participants viewed mPATH-CRC or the Control Program and completed a post-program survey that captured attitudes and beliefs about screening immediately prior to their regularly scheduled primary care appointment. Telephone surveys were administered the next business day to determine if the patients discussed screening with their PCPs; and 24 weeks after the screening visit to determine if screening was ordered and completed.

*PCP = Primary care provider